Dynamics of spontaneous HIV-1 specific and non-specific B-cell responses in patients receiving antiretroviral therapy

AIDS

Volumn 16, Issue 13, 2002, Pages 1755-1760

  Fournier, Anne Marie ^a   Baillat, Vincent ^a   Alix Panabieres, Catherine ^a   Fondere, Jean Michel ^a   Merle, Corinne ^a   Segondy, Michel ^a   Huguet, Marie France ^a   Reynes, Jacques ^a   Vendrell, Jean Pierre ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Combined antiretroviral therapy; HIV 1 specific and non specific B cell activation

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; B-LYMPHOCYTES; DRUG THERAPY, COMBINATION; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; VIRAL LOAD;

EID: 0037032065     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200209060-00007     Document Type: Article

References (22)

1. Amadori A, De Rossi A, Faulkner-Valle GP, Chieco-Bianchi L. Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects. Clin Immunol Immunopathol 1988, 46:342-351.
2. Vendrell JP, Segondy M, Ducos J, et al. Analysis of the spontaneous in vitro anti-HIV-1 antibody secretion by peripheral blood mononuclear cells in HIV-1 infection. Clin Exp Immunol 1991, 83:197-202.
3. Conge AM, Reynes J, Atoui N, et al. Spontaneous in vitro antihuman immunodeficiency virus type 1 antibody secretion by peripheral blood mononuclear cells is related to disease progression in zidovudine-treated adults. J Infect Dis 1994, 170:1376-1383.
4. Pollack H, Zhan MX, Moore T, Tao PZ, Krasinski K, Borkowsky W. Effects of antiviral therapy on the production of anti-human immunodeficiency virus-specific immunoglobulin in infants and children. J Infect Dis 1994, 170:1003-1006.
5. Morris L, Binley JM, Clas BA, et al. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med 1998, 188:233-245.
6. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell and viral generation time. Science 1996, 271:1582-1586.
7. Lafeuillade A, Poggi C, Profizi N, Tamalet C, Costes O. Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma. J Infect Dis 1996, 174:404-407.
8. Tamalet C, Lafeuillade A, Fantini J, Poggi C, Yahi N. Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy. AIDS 1997, 11:895-901.
9. Conge AM, Tarte K, Reynes J, et al. Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease. AIDS 1998, 12:1437-1449.
10. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cells homeostasis and function in advanced HIV disease. Science 199, 277:112-116.
11. Pakker NG, Nothermans D, Boer RJ, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nature Med 1998, 4:208-214.
12. Berberian L, Goodglick L, Kipps TJ, Braun J. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 1993, 261:1588-1591.
13. Karray S, Zouali M. Identification of the B cell superantigen-binding site of HIV-1 gp120. Proc Natl Acad Sci USA 1997, 94:1356-1360.
14. Pahwa S, Pahwa R, Good RA, Gallo RC, Saxinger C. Stimulatory and inhibitory influences of human immunodeficiency virus on normal B-lymphocytes. Proc Natl Acad Sci USA 1986, 83:9124-9128.
15. Cavert W, Notermans DW, Staskus K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997, 276:960-964.
16. Chun TW, Stuyver L, Mizell SB, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Nafi Acad Sci USA 1997, 94:13193-13197.
17. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
18. Hlavacek WS, Wofsy C, Perelson AS. Dissociation of HIV-1 from follicular dendritic cells during HAART: mathematical analysis. Proc Natl Acad Sci USA 1999, 95:14681-14686.
19. Cartry O, Moja P, Quesnel A, Pozetto B, Lucht R, Genin C. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at differnt stages of HIV-1 infection. Clin Exp Immunol 1997, 109:47-53.
20. Devito C, Hinkula J, Kaul R, et al. Mucosal and plsama IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS 2000, 14:1917-1920.
21. Forrest B. Identification of an intestinal immune response using peripheral blood lymphocytes. Lancet 1988, 8577:81-83.
22. Brown K, Kriss J, Moser C, Wenner W, Offit P. Circulating rotavirus-specific antibody-secreting cells (ASCs) predict the presence of circulating rotavirus-specific ASCs in the human small intestinal lamina propria. J Infect Dis 2000, 182:1039-1043.